These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36320663)

  • 61. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
    Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discrimination of SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Using a High-Resolution Melting-Based Assay: a Pilot Study.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    Microbiol Spectr; 2022 Aug; 10(4):e0136722. PubMed ID: 35861527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The First Outbreak of Omicron Subvariant BA.5.2 - Beijing Municipality, China, July 4, 2022.
    Feng Z; Shen Y; Li S; Li J; Wang S; Zhang Z; Shen Y; Li F; Pan Y; Wang Q; Huo D
    China CDC Wkly; 2022 Jul; 4(30):667-668. PubMed ID: 36062071
    [No Abstract]   [Full Text] [Related]  

  • 64. Advances in the Omicron variant development.
    Vitiello A; Ferrara F; Auti AM; Di Domenico M; Boccellino M
    J Intern Med; 2022 Jul; 292(1):81-90. PubMed ID: 35289434
    [TBL] [Abstract][Full Text] [Related]  

  • 65. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.
    Noor R; Shareen S; Billah M
    Bull Natl Res Cent; 2022; 46(1):96. PubMed ID: 35431535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. An Outbreak of SARS-CoV-2 Omicron Subvariant BA.2.76 in an Outdoor Park - Chongqing Municipality, China, August 2022.
    Qi L; Tang W; Wang J; Xiong Y; Yuan Y; Li B; Yang L; Li T; Yang L; Su X; Li Q; Zhang L
    China CDC Wkly; 2022 Nov; 4(46):1039-1042. PubMed ID: 36483192
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.
    Wang L; Cheng G
    J Med Virol; 2022 Apr; 94(4):1728-1733. PubMed ID: 34897752
    [TBL] [Abstract][Full Text] [Related]  

  • 68. COVID-19 rebound after Paxlovid treatment during Omicron BA.5 vs BA.2.12.1 subvariant predominance period.
    Wang L; Volkow ND; Davis PB; Berger NA; Kaelber DC; Xu R
    medRxiv; 2022 Aug; ():. PubMed ID: 35982673
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Whole-Genome Comparison of Representatives of All Variants of SARS-CoV-2, Including Subvariant BA.2 and the GKA Clade.
    Suardana IBK; Mahardika BK; Pharmawati M; Sudipa PH; Sari TK; Mahendra NB; Mahardika GN
    Adv Virol; 2023; 2023():6476626. PubMed ID: 36938489
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Higher SARS-CoV-2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant.
    Li J; Zheng J; Chen P; Wang B; Zhang Y; Xiong J; You L; Jin Y; Jiang L; Tang F; Wen H; Hong C; Zeng X; Li L; Lu B; Rong B; Wang Z
    J Med Virol; 2023 Jan; 95(1):e28365. PubMed ID: 36458536
    [No Abstract]   [Full Text] [Related]  

  • 71. Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes.
    Nchioua R; Diofano F; Noettger S; von Maltitz P; Stenger S; Zech F; Münch J; Sparrer KMJ; Just S; Kirchhoff F
    Signal Transduct Target Ther; 2022 Dec; 7(1):395. PubMed ID: 36566244
    [No Abstract]   [Full Text] [Related]  

  • 72. SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread.
    Wang X; Lu L; Jiang S
    Signal Transduct Target Ther; 2023 Nov; 8(1):439. PubMed ID: 38036521
    [No Abstract]   [Full Text] [Related]  

  • 73. Coding-Complete Genome Sequences of an Omicron Subvariant (BA.5.2.20) of SARS-CoV-2.
    Rhazzar Z; Hemlali M; Melloul M; Ouarab M; Nyabi O; Elouennass M; El Fahime E; Touil N; Gala JL; Ennibi K
    Microbiol Resour Announc; 2023 Jun; 12(6):e0007723. PubMed ID: 37222607
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Insights into the limited global spread of the immune evasive SARS-CoV-2 variant Mu.
    Petrone ME; Lucas C; Menasche B; Breban MI; Yildirim I; Campbell M; Omer SB; Ko AI; Grubaugh ND; Iwasak A; Wilen CB; Vogels CBF; Fauver JR
    medRxiv; 2022 Mar; ():. PubMed ID: 35378749
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Omicron BA.5 Subvariant Provokes the Fifth COVID-19 Wave in Mexico: Closer to the End of This Pandemic.
    De La Cruz-Hernández SI; Álvarez-Contreras AK
    Disaster Med Public Health Prep; 2023 Jan; 17():e344. PubMed ID: 36628619
    [No Abstract]   [Full Text] [Related]  

  • 76. Epidemiological and clinical features of children with the Omicron BA.5.2 subvariant in Guangzhou.
    Li F; He Y; Lan X; Li L; Gu F; Ye Z; Wang L; Cen Z; Zhu W; Yu H
    Signal Transduct Target Ther; 2023 Apr; 8(1):163. PubMed ID: 37185317
    [No Abstract]   [Full Text] [Related]  

  • 77. BF.7 Omicron subvariant in India and China: a raising concern - correspondence.
    Sah R; Mohanty A; Rohilla R; Padhi BK
    Int J Surg; 2023 Mar; 109(3):606-607. PubMed ID: 36912562
    [No Abstract]   [Full Text] [Related]  

  • 78. The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic.
    Rahimi F; Bezmin Abadi AT
    Int J Surg; 2022 Mar; 99():106261. PubMed ID: 35167986
    [No Abstract]   [Full Text] [Related]  

  • 79. Protective effect of plasma neutralization from prior SARS-CoV-2 Omicron infection against BA.5 subvariant symptomatic reinfection.
    Chen X; Xu Y; Xie Y; Song W; Hu Y; Yisimayi A; Yang S; Shao F; Geng L; Wang Y; Gao H; Shi Y; Zhang S; Jin R; Shen Z; Cao Y
    Lancet Reg Health West Pac; 2023 Apr; 33():100758. PubMed ID: 37034408
    [No Abstract]   [Full Text] [Related]  

  • 80. Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6.
    Dijokaite-Guraliuc A; Das R; Nutalai R; Zhou D; Mentzer AJ; Liu C; Supasa P; Dunachie SJ; Lambe T; Fry EE; Mongkolsapaya J; Ren J; Huo J; Stuart DI; Screaton GR
    Cell Discov; 2022 Nov; 8(1):127. PubMed ID: 36443292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.